Skip to main content

Table 3 Number of syncope hospital admissions, diagnosed patients and costs for ILR and CDP groups in different scenarios

From: Financial impact of adopting implantable loop recorder diagnostic for unexplained syncope compared with conventional diagnostic pathway in Portugal

Model output ILR CDP Overall savings
Time horizon Lifetime 3 years Lifetime 3 years Lifetime 3 years
Number of patients diagnosed 175 135 143 40 32 95
Number of patients undiagnosed and alive 1 58 2 152 -1 -94
Total syncope episodes 531 215 1,141 315 610 100
Number of injuries (major and minor) 278 112 596 165 318 53
Costs – device acquisition 394,000€ 394,000€ 0€ 0€ -394,000€ -394,000€
Costs – device-related expenses 71,101€ 71,101€ 0€ 0€ -71,101€ -71,101€
Costs – syncope admissions 705,292€ 353,756€ 1,431,910€ 513,879€ 726,618€ 160,123€
Costs – diagnostic tests* 34,228€ 0€ 139,422€ 50,035€ 105,194€ 50,035€
Costs – total (Sousa Pedro) 1,204,621€ 818,857€ 1,571,332€ 563,915€ 366,711€ -254,943€
Costs – total (Edvardsson) 1,402,037€ 818,857€ 2,375,465€ 852,499€ 973,429€ 33,642€
Costs – total (Baron-Esquivias) 1,188,830€ 818,857€ 1,507,011€ 540,831€ 318,181€ -278,026€
Costs – total (Brignole) 1,206,495€ 818,857€ 1,578,965€ 566,654€ 372,470€ -252,203€
Costs – total (Farwell) 1,185,476€ 818,857€ 1,493,347€ 535,928€ 307,872€ -282,929€
  1. *Diagnostic test costs calculated from resource use data reported by Sousa Pedro [24]. The ‘total’ results for Edvardsson, Baron-Esquivias, Brignole and Farwell instead use the diagnostic test resource use data from the respective studies.